<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M856</article-id>
      <article-id pub-id-type="publisher-id">molbank-2015-M856</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>3-Chlorokenpaullone</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Orban</surname>
            <given-names>Oliver C. F.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Korn</surname>
            <given-names>Ricarda S.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Unger</surname>
            <given-names>Lisa</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yildiz</surname>
            <given-names>Akim</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kunick</surname>
            <given-names>Conrad</given-names>
          </name>
          <xref rid="c1-molbank-2015-M856" ref-type="corresp">*</xref>
        </contrib>
        <contrib contrib-type="editor">
          <name>
            <surname>Haider</surname>
            <given-names>Norbert</given-names>
          </name>
          <role>Academic Editor</role>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2015-M856">Institut f&#xFC;r Medizinische und Pharmazeutische Chemie, Technische Universit&#xE4;t Braunschweig, Beethovenstr. 55, 38106 Braunschweig, Germany</aff>
      <author-notes>
        <corresp id="c1-molbank-2015-M856"><label>*</label> Author to whom correspondence should be addressed; E-Mail: <email>c.kunick@tu-braunschweig.de</email>; Tel. +49-531-391-2754; Fax +49-531-391-2799.</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>30</day>
        <month>04</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>06</month>
        <year>2015</year>
      </pub-date>
      <volume>2015</volume>
      <issue>2</issue>
      <elocation-id>M856</elocation-id>
      <history>
        <date date-type="received">
          <day>03</day>
          <month>04</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>23</day>
          <month>04</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2015 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license>
          <p>This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).</p>
        </license>
      </permissions>
      <abstract>
        <p>3-Chlorokenpaullone (9-bromo-3-chloro-7,12-dihydroindolo[3,2-<italic>d</italic>][1]benz&#xAD;azepin-6(5<italic>H</italic>)-one) is a novel derivative of the protein kinase inhibitor kenpaullone. The title compound was synthesized by a Fischer indole reaction from 8-chloro-3,4-dihydro-1<italic>H</italic>-1-benzazepin-2,5-dione and 4-bromophenylhydrazine. It was characterized for structural identity by elemental analysis and spectroscopic methods (IR, NMR, EI-MS) and checked for purity by HPLC.</p>
      </abstract>
      <kwd-group>
        <kwd>kenpaullone</kwd>
        <kwd>paullone</kwd>
        <kwd>protein kinase inhibitor</kwd>
        <kwd>Fischer indole synthesis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
      <p>Kenpaullone (<bold>1</bold>; <xref ref-type="fig" rid="molbank-2015-M856-f001">Figure 1</xref>) is the eponymous prototype of the paullones [<xref ref-type="bibr" rid="B1-molbank-2015-M856">1</xref>], a class of protein kinase inhibitors structurally based on the 7,12-dihydroindolo[3,2-<italic>d</italic>][1]benzazepin-6(5<italic>H</italic>)-one parent scaffold. </p>
      <p>Kenpaullone was initially identified as a potent inhibitor of cyclin-dependent kinases (CDKs) [<xref ref-type="bibr" rid="B2-molbank-2015-M856">2</xref>]. Later it was shown that kenpaullone also potently inhibits glycogen synthase kinase-3 (GSK-3), a putative target for drugs against diabetes and neurodegenerative diseases [<xref ref-type="bibr" rid="B3-molbank-2015-M856">3</xref>]. In recent stem cell research it was discovered that kenpaullone is able to replace the factor Klf4 in reprogramming murine fibroblasts to pluripotent stem cells [<xref ref-type="bibr" rid="B4-molbank-2015-M856">4</xref>]. Subtle molecular modifications at the kenpaullone structure have a formidable impact on its pharmacological profile [<xref ref-type="bibr" rid="B5-molbank-2015-M856">5</xref>,<xref ref-type="bibr" rid="B6-molbank-2015-M856">6</xref>]. For instance, replacement of C(1) for a nitrogen atom leads to 1-azakenpaullone, a selective GSK-3 inhibitor [<xref ref-type="bibr" rid="B7-molbank-2015-M856">7</xref>]. Further exchange of the bromo substituent for a nitrile group furnishes cazpaullone, a compound protecting pancreatic beta cells against glucolipotoxicity [<xref ref-type="bibr" rid="B8-molbank-2015-M856">8</xref>]. Other paullones were shown to exhibit antiparasitic activity against <italic>Leishmania</italic> [<xref ref-type="bibr" rid="B9-molbank-2015-M856">9</xref>] and <italic>Trypanosoma</italic> [<xref ref-type="bibr" rid="B10-molbank-2015-M856">10</xref>,<xref ref-type="bibr" rid="B11-molbank-2015-M856">11</xref>] parasites. While classical paullones inhibit Sirt1, a NAD<sup>+</sup>-dependent class of histone deacetylases [<xref ref-type="bibr" rid="B12-molbank-2015-M856">12</xref>], it was recently reported that 7-methylene-kenpaullone activates the enzyme [<xref ref-type="bibr" rid="B13-molbank-2015-M856">13</xref>]. In the course of our structure-based development of selective protein kinase inhibitors [<xref ref-type="bibr" rid="B14-molbank-2015-M856">14</xref>,<xref ref-type="bibr" rid="B15-molbank-2015-M856">15</xref>] we were interested to investigate 3-chlorokenpaullone (<bold>4</bold>). To our surprise, a survey of the literature revealed that <bold>4</bold> had not been reported before, neither as characterized compound nor as exemplified prophetic compound in patents. Recently, highly innovative metal-catalyzed paullone syntheses have been reported [<xref ref-type="bibr" rid="B12-molbank-2015-M856">12</xref>,<xref ref-type="bibr" rid="B13-molbank-2015-M856">13</xref>,<xref ref-type="bibr" rid="B16-molbank-2015-M856">16</xref>,<xref ref-type="bibr" rid="B17-molbank-2015-M856">17</xref>]. However, for the sake of simplicity we employed a standard acid-induced Fischer indolization procedure [<xref ref-type="bibr" rid="B18-molbank-2015-M856">18</xref>] for the preparation of <bold>4</bold>, starting from 8-chloro-3,4-dihydro-1<italic>H</italic>-1-benzazepine-2,5-dione (<bold>2</bold>) [<xref ref-type="bibr" rid="B19-molbank-2015-M856">19</xref>] and commercially available 4-bromophenylhydrazine hydrochloride (<bold>3</bold>) (<xref ref-type="scheme" rid="molbank-2015-M856-sch001">Scheme 1</xref>).</p>
    <sec sec-type="results">
      <title>Results and Discussion</title>
      <p>For the preparation of <bold>4</bold>, the cyclic ketone <bold>2</bold> [<xref ref-type="bibr" rid="B19-molbank-2015-M856">19</xref>] was reacted with 4-bromophenyl hydrazine hydrochloride in glacial acetic acid at 70 &#xB0;C in a two-step, one-pot method. In the presence of sodium acetate a phenyl hydrazone was formed, which was directly cyclized upon addition of concentrated sulfuric acid. Without the need for chromatographic purification, a moderated yield of analytical pure product was collected after crystallization from ethanol. Both isocratic and gradient HPLC methods indicated a degree of purity of the crystallized compound sufficient for biological studies (&gt;95%). As expected, the IR spectrum displayed absorption maxima for the N-H (3223 cm<sup>&#x2212;1</sup>) and C=O (1647 cm<sup>&#x2212;1</sup>) stretching vibrations. In the <sup>1</sup>H-NMR spectrum, the methylene group appeared as a singlet at 3.56 ppm, indicating a rapid inversion of the two mirror-imaged pseudoboat conformations of the azepine ring, leading to isochrony of the methylene protons. Besides the expected signals for the fourteen aromatic carbons, the signals of the methylene carbon (31.4 ppm) and carbonyl carbon (171.4 ppm) were unambiguously identified in the <sup>13</sup>C-NMR spectrum. In the EI mass spectrum, a [M-29]<sup>+</sup> signal was observed. This cation results from the loss of a CHO unit from the molecular ion and is characteristic for paullones [<xref ref-type="bibr" rid="B10-molbank-2015-M856">10</xref>].</p>
    </sec>
    <sec sec-type="methods">
      <title>Experimental</title>
      <sec>
        <title>General</title>
        <p>4-Bromophenylhydrazine hydrochloride <bold>3</bold> was purchased from Sigma Aldrich. The melting point was detected in an open-glass capillary on an electric variable heater (Electrothermal IA 9100). The infrared spectrum was recorded on a Thermo Nicolet FT-IR 200 spectrometer using KBr pellets. The <sup>13</sup>C-NMR and the <sup>1</sup>H-NMR spectra were recorded on a Bruker Avance AV II-600 spectrometer (Bruker Corporation, Billerica, MA, USA) (NMR Laboratories of the Chemical Institutes of the Technische Universit&#xE4;t Braunschweig) in DMSO-<italic>d</italic><sub>6</sub>. Chemical shifts are presented in relation to TMS (&#x3B4; = 0 ppm). C nuclei were assigned based on results of a <sup>13</sup>C-DEPT135 experiment. HPLC was performed on a Merck Hitachi LaChrom Elite system (Hitachi High Technologies Inc., San Jose, CA, USA) (DAD detector: L-2450 (isocrat), UV detector: L-2400 (gradient); pump: L-2130; autosampler: L-2200; column: Merck LiChroCART 125-4, LiChrospher 100 RP-18 (5 &#x3BC;m); isocratic eluent: acetonitrile/water mixture 50:50; gradient elution: concentration acetonitril 0&#x2013;2 min: 10%; 2&#x2013;12 min: 10% &#x2192; 90% (linear) 12&#x2013;20 min: 90%; elution rate: 1.000 mL/min; detection wavelength: 254 nm and 280 nm (isocrat.), 254 nm (gradient); overall run time: 15 min. (isocrat.); t<sub>s</sub> = dead time; t<sub>ms</sub> = total retention time). For mass spectrometry a MAT95XL spectrometer was used (Thermofinnigan MAT, Bremen, Germany, Department of Mass Spectrometry of the Chemical Institutes of the Technische Universit&#xE4;t Braunschweig). The elemental analysis was performed on a CE Instruments Flash EA&#xAE; 1112 Elemental Analyzer. TLC: Polygram SIL G/UV<sub>254</sub>, 0.2 mm thickness, (Macherey-Nagel).</p>
      </sec>
      <sec>
        <title>9-Bromo-3-chloro-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one (<italic><bold>4</bold></italic>)</title>
        <p>8-Chloro-3,4-dihydro-1<italic>H</italic>-1-benzazepin-2,5-dione (<bold>2</bold>, 211 mg, 1.01 mmol) [<xref ref-type="bibr" rid="B19-molbank-2015-M856">19</xref>] and 4-bromo&#xAD;phenylhydrazine hydrochloride (<bold>3</bold>, 298 mg, 1.33 mmol) were suspended in glacial acetic acid (10.0 mL) and anhydrous sodium acetate (113 mg, 1.38 mmol) was added. The mixture was stirred for 1 h at 70 &#xB0;C. Concentrated sulfuric acid (100 &#xB5;L) was added and stirring was continued for 1.25 h at 70 &#xB0;C. After the mixture was cooled down to room temperature, 5% aqueous sodium acetate solution (20.0 mL) was added. The mixture was stored overnight at 6 &#xB0;C. An orange precipitate formed which was filtered off, washed with water and crystallized from ethanol to yield a yellow powder (151 mg, 41.8%).</p>
        <p>M.p.: 247&#x2013;249 &#xB0;C (dec.).</p>
        <p>MS (EI, rel. intensity) <italic>m/z</italic>: 362 ([M]<sup>+&#x2022;</sup>, 100), 333 ([M-29 (-CHO)]<sup>+</sup>, 62).</p>
        <p>IR (KBr) (cm<sup>&#x2212;1</sup>): 3223 (N-H), 1647 (C=O).</p>
        <p><sup>1</sup>H-NMR (600.1 MHz, DMSO-<italic>d<sub>6</sub></italic>): &#x3B4; (ppm) = 11.87 (s, 1H, NH-indole), 10.23 (s, 1H, NH-lactam), 7.93 (d, <italic>J</italic> = 1.9 HZ, 1H, ArH), 7.74 (d, <italic>J</italic> = 8.5 Hz, 1H, ArH), 7.40 (d, <italic>J</italic> = 8.4 Hz, 1H, ArH), 7.37 (dd, <italic>J</italic> = 8.4, 2.1 Hz, 1H, ArH), 7.31 (d, <italic>J</italic> = 2.2 Hz, 1H, ArH), 7.29 (dd, <italic>J</italic> = 8.6, 1.9 Hz, 1H, ArH), 3.56 (s, 2H, -CH<sub>2</sub>).</p>
        <p><sup>13</sup>C-NMR (151 MHz, DMSO-<italic>d<sub>6</sub></italic>): &#x3B4; (ppm) = 31.35 (CH<sub>2</sub>); 113.47, 120.59, 121.24, 123.54, 124.84, 128.24 (CH); 107.43, 111.82, 121.57, 128.61, 132.43, 133.01, 136.13, 136.78, 171.40 (C).</p>
        <p>HPLC (AUC %): 98.74% at 254 nm; 98.00% at 280 nm, t<sub>ms</sub> = 5.88 min, t<sub>s</sub> (DMSO) = 1.06 min (isocrat); 95.43% at 254 nm, t<sub>ms</sub> = 12.02 min (gradient).</p>
        <p>TLC (petroleum ether/ethyl acetate 50:50): R<sub>f</sub> = 0.73. </p>
        <p>Anal. calculated for C<sub>16</sub>H<sub>10</sub>BrClN<sub>2</sub>O (361.62): C, 53.14; H, 2.79; N, 7.75. Found: C, 53.21; H, 2.77; N, 7.51.</p>
      </sec>
    </sec>
  </body>
  <back>
    <app-group>
    <app id="app1-molbank-2015-M856">
        <title>Supplementary materials</title>
        <supplementary-material id="molbank-2015-M856-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2015-M856-s001-mod.mol">
        <label>Supplementary File 1</label>
        </supplementary-material>
        <supplementary-material id="molbank-2015-M856-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2015-M856-s001.mol">
        <label>Supplementary File 2</label>
        </supplementary-material>
    </app>
    </app-group>
    <ack>
      <title>Acknowledgments</title>
      <p>This project was in part funded by the German &#x201C;Bundesministerium f&#xFC;r Bildung und Forschung&#x201D; (KMU-innovativ 5, F&#xF6;rderkennzeichen 0315814; to R. S. K. and C. K.). The authors are grateful to U. Papke for recording the mass spectrum, to S. Meyer and P. Reich for recording the IR spectrum and performing the elementary analysis and to K. Ibrom for recording the <sup>1</sup>H-NMR and <sup>13</sup>C-NMR spectrum.</p>
    </ack>
    <notes>
      <title>Author Contributions</title>
      <p>Lisa Unger, Akim Yildiz: Experimental synthetic work, HPLC, writing of manuscript; Oliver C. F. Orban, Ricarda S. Korn: Experimental synthetic work, literature search, HPLC, NMR and MS interpretation; Conrad Kunick: Synthesis planning, literature search, writing of manuscript.</p>
    </notes>
    <notes>
      <title>Conflicts of Interest</title>
      <p>The authors declare no conflict of interest.</p>
    </notes>
    <ref-list>
      <title>References</title>
      <ref id="B1-molbank-2015-M856">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tolle</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Kunick</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Paullones as inhibitors of protein kinases</article-title>
          <source>Curr. Top. Med. Chem.</source>
          <year>2011</year>
          <volume>11</volume>
          <fpage>1320</fpage>
          <lpage>1332</lpage>
          <pub-id pub-id-type="doi">10.2174/156802611795589601</pub-id>
          <pub-id pub-id-type="pmid">21513499</pub-id>
        </citation>
      </ref>
      <ref id="B2-molbank-2015-M856">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sausville</surname>
              <given-names>E.A.</given-names>
            </name>
            <name>
              <surname>Zaharevitz</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Gussio</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Meijer</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Louarn-Leost</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kunick</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Schultz</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Lahusen</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Headlee</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Stinson</surname>
              <given-names>S.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cyclin-dependent kinases: Initial approaches to exploit a novel therapeutic target</article-title>
          <source>Pharmacol. Ther.</source>
          <year>1999</year>
          <volume>82</volume>
          <fpage>285</fpage>
          <lpage>292</lpage>
          <pub-id pub-id-type="doi">10.1016/S0163-7258(98)00062-X</pub-id>
        </citation>
      </ref>
      <ref id="B3-molbank-2015-M856">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leost</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Schultz</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Link</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>Y.-Z.</given-names>
            </name>
            <name>
              <surname>Biernat</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Mandelkow</surname>
              <given-names>E.-M.</given-names>
            </name>
            <name>
              <surname>Bibb</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Snyder</surname>
              <given-names>G.L.</given-names>
            </name>
            <name>
              <surname>Greengard</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Zaharevitz</surname>
              <given-names>D.W.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Paullones are potent inhibitors of glycogen synthase kinase-3beta and cyclin-dependent kinase 5/p25</article-title>
          <source>Eur. J. Biochem.</source>
          <year>2000</year>
          <volume>267</volume>
          <fpage>5983</fpage>
          <lpage>5994</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1432-1327.2000.01673.x</pub-id>
          <pub-id pub-id-type="pmid">10998059</pub-id>
        </citation>
      </ref>
      <ref id="B4-molbank-2015-M856">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lyssiotis</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Foreman</surname>
              <given-names>R.K.</given-names>
            </name>
            <name>
              <surname>Staerk</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Garcia</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Mathur</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Markoulaki</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Hanna</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Lairson</surname>
              <given-names>L.L.</given-names>
            </name>
            <name>
              <surname>Charette</surname>
              <given-names>B.D.</given-names>
            </name>
            <name>
              <surname>Bouchez</surname>
              <given-names>L.C.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <year>2009</year>
          <volume>106</volume>
          <fpage>8912</fpage>
          <lpage>8917</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0903860106</pub-id>
          <pub-id pub-id-type="pmid">19447925</pub-id>
        </citation>
      </ref>
      <ref id="B5-molbank-2015-M856">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pies</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Schaper</surname>
              <given-names>K.-J.</given-names>
            </name>
            <name>
              <surname>Leost</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Zaharevitz</surname>
              <given-names>D.W.</given-names>
            </name>
            <name>
              <surname>Gussio</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Meijer</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Kunick</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>CDK1-inhibitory activity of paullones depends on electronic properties of 9-substituents</article-title>
          <source>Arch. Pharm. Pharm. Med. Chem.</source>
          <year>2004</year>
          <volume>337</volume>
          <fpage>486</fpage>
          <lpage>492</lpage>
          <pub-id pub-id-type="doi">10.1002/ardp.200300870</pub-id>
          <pub-id pub-id-type="pmid">15362121</pub-id>
        </citation>
      </ref>
      <ref id="B6-molbank-2015-M856">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xie</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Lemcke</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Gussio</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Zaharevitz</surname>
              <given-names>D.W.</given-names>
            </name>
            <name>
              <surname>Leost</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Meijer</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Kunick</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Epoxide-containing side chains enhance antiproliferative activity of paullones</article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>2005</year>
          <volume>40</volume>
          <fpage>655</fpage>
          <lpage>661</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejmech.2005.02.004</pub-id>
          <pub-id pub-id-type="pmid">15935900</pub-id>
        </citation>
      </ref>
      <ref id="B7-molbank-2015-M856">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kunick</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Lauenroth</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Leost</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Meijer</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Lemcke</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>1-Azakenpaullone is a selective inhibitor of glycogen synthase kinase-3</article-title>
          <source>Bioorg. Med. Chem. Lett.</source>
          <year>2004</year>
          <volume>14</volume>
          <fpage>413</fpage>
          <lpage>416</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmcl.2003.10.062</pub-id>
          <pub-id pub-id-type="pmid">14698171</pub-id>
        </citation>
      </ref>
      <ref id="B8-molbank-2015-M856">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stukenbrock</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Mussmann</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Geese</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Ferandin</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Lozach</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Lemcke</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Kegel</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Lomow</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Burk</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Dohrmann</surname>
              <given-names>C.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>9-Cyano-1-azapaullone (cazpaullone), a glycogen synthase kinase-3 (GSK-3) inhibitor activating pancreatic beta cell protection and replication</article-title>
          <source>J. Med. Chem.</source>
          <year>2008</year>
          <volume>51</volume>
          <fpage>2196</fpage>
          <lpage>2207</lpage>
          <pub-id pub-id-type="doi">10.1021/jm701582f</pub-id>
          <pub-id pub-id-type="pmid">18345612</pub-id>
        </citation>
      </ref>
      <ref id="B9-molbank-2015-M856">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reichwald</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Shimony</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Dunkel</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Sacerdoti-Sierra</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Jaffe</surname>
              <given-names>C.L.</given-names>
            </name>
            <name>
              <surname>Kunick</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>2-(3-Aryl-3-oxopropen-1-yl)-9-<italic>tert</italic>-butyl-paullones: a new antileishmanial chemotype</article-title>
          <source>J. Med. Chem.</source>
          <year>2008</year>
          <volume>51</volume>
          <fpage>659</fpage>
          <lpage>665</lpage>
          <pub-id pub-id-type="doi">10.1021/jm7012166</pub-id>
          <pub-id pub-id-type="pmid">18186603</pub-id>
        </citation>
      </ref>
      <ref id="B10-molbank-2015-M856">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maiwald</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Ben&#xED;tez</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Charquero</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Dar</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Erdmann</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Preu</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Koch</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>H&#xF6;lscher</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Loa&#xEB;c</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Meijer</surname>
              <given-names>L.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>9- and 11-substituted 4-azapaullones are potent and selective inhibitors of African trypanosoma</article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>2014</year>
          <volume>83</volume>
          <fpage>274</fpage>
          <lpage>283</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejmech.2014.06.020</pub-id>
          <pub-id pub-id-type="pmid">24973661</pub-id>
        </citation>
      </ref>
      <ref id="B11-molbank-2015-M856">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ryczak</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Papini</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Lader</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Nasereddin</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Kopelyanskiy</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Preu</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Jaffe</surname>
              <given-names>C.L.</given-names>
            </name>
            <name>
              <surname>Kunick</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>2-Arylpaullones are selective antitrypanosomal agents</article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>2013</year>
          <volume>64</volume>
          <fpage>396</fpage>
          <lpage>400</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejmech.2013.03.065</pub-id>
          <pub-id pub-id-type="pmid">23648975</pub-id>
        </citation>
      </ref>
      <ref id="B12-molbank-2015-M856">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Soto</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Vaz</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Dell&#x2019;Aversana</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Alvarez</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Altucci</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>de Lera</surname>
              <given-names>A.R.</given-names>
            </name>
          </person-group>
          <article-title>New synthetic approach to paullones and characterization of their SIRT1 inhibitory activity</article-title>
          <source>Org. Biomol. Chem.</source>
          <year>2012</year>
          <volume>10</volume>
          <fpage>2101</fpage>
          <lpage>2112</lpage>
          <pub-id pub-id-type="doi">10.1039/c2ob06695e</pub-id>
          <pub-id pub-id-type="pmid">22286328</pub-id>
        </citation>
      </ref>
      <ref id="B13-molbank-2015-M856">
        <label>13.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Denis</surname>
              <given-names>J.G.</given-names>
            </name>
            <name>
              <surname>Franci</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Altucci</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Aurrecoechea</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>de Lera</surname>
              <given-names>A.R.</given-names>
            </name>
            <name>
              <surname>Alvarez</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of 7-alkylidene-7,12-dihydroindolo[3,2-<italic>d</italic>]benzazepine-6-(5<italic>H</italic>)-ones (7-alkylidene-paullones) by N-cyclization-oxidative Heck cascade and characterization as sirtuin modulators</article-title>
          <source>Org. Biomol. Chem.</source>
          <year>2015</year>
          <volume>13</volume>
          <fpage>2800</fpage>
          <lpage>2810</lpage>
          <pub-id pub-id-type="doi">10.1039/C4OB02493A</pub-id>
          <pub-id pub-id-type="pmid">25604354</pub-id>
        </citation>
      </ref>
      <ref id="B14-molbank-2015-M856">
        <label>14.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Egert-Schmidt</surname>
              <given-names>A.-M.</given-names>
            </name>
            <name>
              <surname>Dreher</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Dunkel</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Kohfeld</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Preu</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Weber</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Ehlert</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Mutschler</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Totzke</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Sch&#xE4;chtele</surname>
              <given-names>C.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Identification of 2-anilino-9-methoxy-5,7-dihydro-6<italic>H</italic>-pyrimido[5,4-<italic>d</italic>][1]benzazepin-6-ones as dual PLK1/VEGF-R2 kinase inhibitor chemotypes by structure-based lead generation</article-title>
          <source>J. Med. Chem.</source>
          <year>2010</year>
          <volume>53</volume>
          <fpage>2433</fpage>
          <lpage>2442</lpage>
          <pub-id pub-id-type="doi">10.1021/jm901388c</pub-id>
          <pub-id pub-id-type="pmid">20170163</pub-id>
        </citation>
      </ref>
      <ref id="B15-molbank-2015-M856">
        <label>15.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McGrath</surname>
              <given-names>C.F.</given-names>
            </name>
            <name>
              <surname>Pattabiraman</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Kellogg</surname>
              <given-names>G.E.</given-names>
            </name>
            <name>
              <surname>Lemcke</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Kunick</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Sausville</surname>
              <given-names>E.A.</given-names>
            </name>
            <name>
              <surname>Zaharevitz</surname>
              <given-names>D.W.</given-names>
            </name>
            <name>
              <surname>Gussio</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Homology model of the CDK1/cyclin B complex</article-title>
          <source>J. Biomol. Struct. Dyn.</source>
          <year>2005</year>
          <volume>22</volume>
          <fpage>493</fpage>
          <lpage>502</lpage>
          <pub-id pub-id-type="doi">10.1080/07391102.2005.10531227</pub-id>
          <pub-id pub-id-type="pmid">15702922</pub-id>
        </citation>
      </ref>
      <ref id="B16-molbank-2015-M856">
        <label>16.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saget</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Cramer</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>Enantioselective C-H arylation strategy for functionalized dibenzazepinones with quaternary stereocenters</article-title>
          <source>Angew. Chem. Int. Ed. Engl.</source>
          <year>2013</year>
          <volume>125</volume>
          <fpage>8019</fpage>
          <lpage>8022</lpage>
          <pub-id pub-id-type="doi">10.1002/ange.201303816</pub-id>
        </citation>
      </ref>
      <ref id="B17-molbank-2015-M856">
        <label>17.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsyshchuk</surname>
              <given-names>I.E.</given-names>
            </name>
            <name>
              <surname>Vorobyeva</surname>
              <given-names>D.V.</given-names>
            </name>
            <name>
              <surname>Peregudov</surname>
              <given-names>A.S.</given-names>
            </name>
            <name>
              <surname>Osipov</surname>
              <given-names>S.N.</given-names>
            </name>
          </person-group>
          <article-title>Cu-catalyzed carbenoid functionalization of indoles by methyl 3,3,3-trifluoro-2-diazopropionate</article-title>
          <source>Eur. J. Org. Chem.</source>
          <year>2014</year>
          <volume>2014</volume>
          <fpage>2480</fpage>
          <lpage>2486</lpage>
          <pub-id pub-id-type="doi">10.1002/ejoc.201301734</pub-id>
        </citation>
      </ref>
      <ref id="B18-molbank-2015-M856">
        <label>18.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Falke</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Bumiller</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Harbig</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Masch</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Wobbe</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Kunick</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>2-<italic>tert</italic>-Butyl-5,6,7,8,9,10-hexahydrocyclohepta[<italic>b</italic>]indole</article-title>
          <source>Molbank</source>
          <year>2011</year>
          <volume>2011</volume>
          <fpage>M737</fpage>
          <pub-id pub-id-type="doi">10.3390/M737</pub-id>
        </citation>
      </ref>
      <ref id="B19-molbank-2015-M856">
        <label>19.</label>
        <citation citation-type="patent">
          <person-group person-group-type="author">
            <name>
              <surname>Sattlegger</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Buschmann</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Przewosny</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Englberger</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Koegel</surname>
              <given-names>B.-Y.</given-names>
            </name>
            <name>
              <surname>Schick</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Preparation of 2<italic>H</italic>-1-Benzazepin-2-ones as Analgesics</article-title>
          <source>PCT Int. Appl.</source>
          <patent>WO 2003037873 A1</patent>
          <day>8</day>
          <month>May</month>
          <year>2003</year>
        </citation>
      </ref>
    </ref-list>
    <sec sec-type="display-objects">
      <title>Figure and Scheme</title>
      <fig id="molbank-2015-M856-f001" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Structure of kenpaullone (<bold>1</bold>).</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2015-M856-g001.tif"/>
      </fig>
      <fig id="molbank-2015-M856-sch001" position="float">
        <object-id pub-id-type="pii">molbank-2015-M856-sch001_Scheme 1</object-id>
        <label>Scheme 1</label>
        <caption>
          <p>Synthesis of 3-chlorokenpaullone (<bold>4</bold>) by Fischer indole ring closure. <italic>Reagents and conditions</italic>: (i) 1. AcOH, NaOAc, 70 &#xB0;C, 1 h; 2. AcOH, H<sub>2</sub>SO<sub>4</sub>, 70 &#xB0;C, 1 h.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2015-M856-sch001.tif"/>
      </fig>
    </sec>
  </back>
</article>
